A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies.

Mosialou I, Ali AM, Labella R, Bisikirska B, Cuesta-Dominguez A, Vgenopoulou P, Reyes I, Rao SM, Wang A, Luo N, Galan-Diez M, Zhao J, Chernak BJ, Bewersdorf JP, Fukasawa K, Su J, Higa J, Adams RA, Corper AL, Pampou S, Woods CM, Fan X, Shah RP, Feldstein J, Liu N, Liang C, Heiblig M, Kornblau S, Garcia-Manero G, Berman E, Jurcic JG, Rabadan R, Raza A, Kousteni S

Open source

DOI: 10.1016/j.ccell.2025.03.007
Published: 2025 Jun 9
Container: Cancer cell
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ccell.2025.03.007,
  title = {A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies.},
  author = {Mosialou I and Ali AM and Labella R and Bisikirska B and Cuesta-Dominguez A and Vgenopoulou P and Reyes I and Rao SM and Wang A and Luo N and Galan-Diez M and Zhao J and Chernak BJ and Bewersdorf JP and Fukasawa K and Su J and Higa J and Adams RA and Corper AL and Pampou S and Woods CM and Fan X and Shah RP and Feldstein J and Liu N and Liang C and Heiblig M and Kornblau S and Garcia-Manero G and Berman E and Jurcic JG and Rabadan R and Raza A and Kousteni S},
  year = {2025},
  journal = {Cancer cell},
  doi = {10.1016/j.ccell.2025.03.007},
  url = {https://doi.org/10.1016/j.ccell.2025.03.007}
}

RIS

TY  - JOUR
TI  - A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies.
AU  - Mosialou I
AU  - Ali AM
AU  - Labella R
AU  - Bisikirska B
AU  - Cuesta-Dominguez A
AU  - Vgenopoulou P
AU  - Reyes I
AU  - Rao SM
AU  - Wang A
AU  - Luo N
AU  - Galan-Diez M
AU  - Zhao J
AU  - Chernak BJ
AU  - Bewersdorf JP
AU  - Fukasawa K
AU  - Su J
AU  - Higa J
AU  - Adams RA
AU  - Corper AL
AU  - Pampou S
AU  - Woods CM
AU  - Fan X
AU  - Shah RP
AU  - Feldstein J
AU  - Liu N
AU  - Liang C
AU  - Heiblig M
AU  - Kornblau S
AU  - Garcia-Manero G
AU  - Berman E
AU  - Jurcic JG
AU  - Rabadan R
AU  - Raza A
AU  - Kousteni S
PY  - 2025
JO  - Cancer cell
DO  - 10.1016/j.ccell.2025.03.007
UR  - https://doi.org/10.1016/j.ccell.2025.03.007
ER  -

APA

I, M., AM, A., R, L., B, B., A, C., P, V., I, R., SM, R., A, W., N, L., M, G., J, Z., BJ, C., JP, B., K, F., J, S., J, H., RA, A., AL, C., S, P., CM, W., X, F., RP, S., J, F., N, L., C, L., M, H., S, K., G, G., E, B., JG, J., R, R., A, R., & S, K. (2025). A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies.. Cancer cell. https://doi.org/10.1016/j.ccell.2025.03.007

Source records

pubmed · retrieved 2026-09-27T11:46:53.464Z